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SimulConsult, Inc., Brookline, MassachusettsThe irony of predictions such as “attention deﬁcit hy-
peractivity disorder (ADHD) does not exist” is that once
knowledge has advanced enough to settle the question, it is
no longer clear what the question meant in the ﬁrst place.
“ADHD Does Not Exist” is the title of a recent book by
neurologist Richard Saul,1 which gives a detailed differen-
tial diagnosis of attention deﬁcit, with the noble goal of
reducing the indiscriminant use of stimulant drugs.
Similar questions have also been raised in scientiﬁc jour-
nals, notably by Warren Weinberg and Roger Brumback
in their 1992 article “The myth of attention deﬁcit-
hyperactivity disorder: symptoms resulting from multiple
causes”.2
Everyone agrees on the basics. Everyone agrees that
there is a ﬁnding that we term “attention deﬁcit.” Everyone
agrees that many diseases, as well as states such as sleep
deprivation, have the ﬁnding “attention deﬁcit.” The con-
troversy boils down to whether there is at least one disease
entity that we would consider to be primary attention
deﬁcit, with no other obvious abnormal ﬁndings.
I am convinced that this is true, within current deﬁni-
tions. The uncertainty in my mind is what we will decide
that “obvious” and “abnormal” mean once we have enough
knowledge to answer the question.
This perspective comes from the study of families with
no obvious ﬁndings other than attention deﬁcit, apparently
inherited in an autosomal dominant fashion. However, the
affected individuals also have a biological marker, one
typically not tested, but suggestive of a channelopathy:
reduced effectiveness of lidocaine. This is most conve-
niently demonstrated using lidocaine gel on the tongue, but
most convincingly demonstrated by injection of lidocaine in
a nondental area and observing negligible loss of sensation.* This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).
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periodic paralysis, such as amelioration by potassium and
exacerbation by sodium or glucose. We termed this “hy-
pokalemic sensory overstimulation”, and Roger Brumback
published our description of the ﬁrst family in the Journal of
Child Neurology.3 With tens of families now known to have
this clinical picture, channelopathy geneticists are zeroing
in on the relevant gene. Although this familial attention
deﬁcit with lidocaine ineffectiveness is found in less than
half of people with attention deﬁcit, it may provide a useful
model for thinking about ADHD.
Do these families provide an example of primary ADHD?
That depends on whether lidocaine ineffectiveness dis-
qualiﬁes people with attention deﬁcit from having “pri-
mary” ADHD. Is this disorder properly classiﬁed as ADHD?
In many of the families, individuals got a diagnosis of ADHD
or Asperger syndrome almost interchangeably, for much
the same collection of ﬁndings, suggesting that the care
devoted by the American Psychiatric Association to crafting
the deﬁnitions of such disorders in the latest iteration of the
Diagnostic and Statistical Manual of Mental Disorders was
not particularly useful.
Is ADHD even abnormal? It seems abnormal when we
consider children who are asked to sit quietly in school and
work in small groups and asked to ignore other small
groups nearby and small animals they see out the window.
But thousands of years ago, when our ancestors were
hunters, noticing prey and predators was very adaptive.
Anyonewho has seen someonewith ADHD save a drowning
child who was unnoticed by “normals” will wonder, who is
abnormal? If children with ADHD become symptomatic
because of high sodium in our diet, are these children
abnormal or is our diet abnormal? If an adult with attention
deﬁcit is successful as a venture capitalist by always looking
around for the next deal, is that adult abnormal, or is their
“disorder” useful, or both?
These are questions of opinion and deﬁnition. But they
generate many testable hypotheses. Does sodium restric-
tion reduce attention deﬁcit? Is attention deﬁcit less a
problem in climates inwhich people lose sodiumvia sweat?reserved.
M.M. Segal / Pediatric Neurology 51 (2014) 15e1616Do people with sensory overstimulation and lidocaine
ineffectiveness get less sleep than others, and should they
be particularly careful about not using bright screens past 9
pm? Does stratifying childrenwith attention deﬁcit by their
lidocaine response reveal one group that gets worse with
sugar, and another group that gets better with sugar,
perhaps because of mitochondrial mutations, and does an
aggregate of both groups give a result of sugar having no
effect on attention deﬁcit? Is lidocaine ineffectiveness more
common in tribes of hunters? Were the genetic variants
underlying lidocaine ineffectiveness more common tens of
thousands of years ago? As people migrated to the cold
climates of northern Europe thousands of years ago and
engaged in agriculture instead of hunting, did monoallelic
variants in genes that result in increased sodium loss, such
as CFTR, have a selective beneﬁt?
There is no unique answer to the question of whether
ADHD exists; the answer depends on what we mean by
“obvious other ﬁndings” and “abnormal.” But the discussion
of whether ADHD exists generates a host of fascinating
questions, some with major implications for therapeutics.
The best way to do such studies is with an identiﬁed gene,
but we may be able to make some modest progress in the
interim by studying people with attention deﬁcit and bio-
logical markers such as lidocaine ineffectiveness.
In the differential diagnosis for the ﬁnding of attention
deﬁcit, Weinberg and Brumback posited an entity that theycalled “primary disorder of vigilance” and Saul posits an
entity called “neurochemical distractibility/impulsivity”. It
seems likely that these entities, as well as ADHD, Asperger
syndrome, sensory processing disorder, ﬁbromyalgia, pre-
menstrual syndrome and hypokalemic sensory over-
stimulation, are all descriptions of overlapping disorders of
sensory input and attention. Over the coming decades, we
will use mechanistic and genetic approaches to take apart
this amalgamation and put it back together using biological
criteria. No single gene is likely to explain most people with
attention deﬁcit. Experience from watching the tide of ge-
netic analysis sweep over other areas of diagnosis suggests
that once we start to ﬁnd molecular mechanisms for some
forms of attention deﬁcit, it will become cleaner to study
other forms. Once we have biological diagnoses for the
various forms of attention deﬁcit, and corresponding ther-
apies targeted to the molecular mechanisms, people will
wonder what wewere talking about whenwe discussed the
question of whether ADHD exists.
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